Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Robert Freedman to Treatment Outcome

This is a "connection" page, showing publications Robert Freedman has written about Treatment Outcome.

 
Connection Strength
 
 
 
0.163
 
  1. Freedman R. Ketamine and ECT in Depression - Risks and Rewards. N Engl J Med. 2023 06 22; 388(25):2389-2390.
    View in: PubMed
    Score: 0.066
  2. Olincy A, Blakeley-Smith A, Johnson L, Kem WR, Freedman R. Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder. J Autism Dev Disord. 2016 Dec; 46(12):3812-3817.
    View in: PubMed
    Score: 0.042
  3. Freedman R, Carpenter WT, Davis JM, Goldman HH, Tamminga CA, Thomas M. The costs of drugs for schizophrenia. Am J Psychiatry. 2006 Dec; 163(12):2029-31.
    View in: PubMed
    Score: 0.021
  4. Gabbard GO, Freedman R. Psychotherapy in the Journal: what's missing? Am J Psychiatry. 2006 Feb; 163(2):182-4.
    View in: PubMed
    Score: 0.020
  5. Kantrowitz JT, Javitt DC, Freedman R, Sehatpour P, Kegeles LS, Carlson M, Sobeih T, Wall MM, Choo TH, Vail B, Grinband J, Lieberman JA. Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients. Neuropsychopharmacology. 2020 07; 45(8):1339-1345.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)